MaxCyte, Inc.

MXCT·NasdaqGS·Healthcare
Compare
1.3900−0.0700 (−4.79%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close1.4600
Open1.4700
Day range1.36001.4800
52-week range0.64301.8050
Off day high−6.08%
Off 52-week high−22.99%
Volume855.96K
Avg. volume (3M)920.25K
Market cap143.46M
EPS (TTM)-0.3400
Forward P/E-5.64
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)1.48
Shares outstanding103.21M
Short interest1.79% of float
Earnings dateNov 10, 2026
Analyst target4.1075
Profit margin−114.77%

Against its peers

Compare in full ›
MXCT LAB CTKB ALERS.PA CHY.F CTSO
Market cap 143.46M 243.14M 764.30M 265.30M 1.47B 14.37M
P/E (TTM) — — — 37.6 55.2 —
Forward P/E -5.6 -61.6 84.0 23.3 — —
Price/book 0.9 0.4 2.2 1.4 15.3 -19.1
Dividend yield — — — — — —
1-year change −12.57% −46.49% +48.63% +9.56% −18.93% −69.53%
Today −4.79% +0.85% −1.34% 0.00% −0.47% +0.44%

The closest companies by business and industry (Medical Devices). Prices may be delayed up to 15 min.

Latest news

All MXCT news ›
Stock Titan·

MaxCyte shareholder Liontrust reports 5.033% stake

An investor reports over 5% of MaxCyte (MXCT) after October 14 share purchases. Stock Titan Sales are listed in September and on October 7, 2026, before purchase entries dated October 14, 2026. MaxCyte, Inc. (MXCT) is the issuer in a…

Stock Titan·Positive

MaxCyte expects about 15% H2 core revenue growth

Liberty Energy Inc. Announces Third Quarter 2026 Financial and Operational Results MaxCyte’s revised outlook calls for approximately 15% year-over-year core business revenue growth in the second half of 2026. MaxCyte (MXCT) reported…

From the 4Search news index, newest first.

In the news

8mentions in 30 days
8with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 8 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance